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Abstract
Introduction
The incidence of unplanned dialysis initiation (DI) with consequent increased comorbidity,
mortality and reduced modality choice remains high, but the optimal timing of dialysis initia-
tion (DI) remains controversial, and there is a lack of studies of specific reasons for DI. We
investigated why and when physicians prescribe dialysis and hypothesized that physician
motivation for DI is an independent factor which may have clinical consequences.
Methods
In the Peridialysis study, an ongoing multicenter prospective study assessing the causes
and timing of DI and consequences of unplanned dialysis, physicians in 11 hospitals were
asked to describe their primary, secondary and further reasons for prescribing DI. The
stated reasons for DI were analyzed in relation to clinical and biochemical data at DI, and
characteristics of physicians.
Results
In 446 patients (median age 67 years; 38% females; diabetes 25.6%), DI was prescribed by
84 doctors who stated 23 different primary reasons for DI. The primary indication was clini-
cal in 63% and biochemical in 37%; 23% started for life-threatening conditions. Reduced
renal function accounted for only 19% of primary reasons for DI but was a primary or contrib-
uting reason in 69%. The eGFR at DI was 7.2 ±3.4 ml/min/1.73 m2, but varied according to
comorbidity and cause of DI. Patients with cachexia, anorexia and pulmonary stasis (34%
with heart failure) had the highest eGFR (8.2–9.8 ml/min/1.73 m2), and those with edema,
“low GFR”, and acidosis, the lowest (4.6–6.1 ml/min/1.73 m2). Patients with multiple
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comorbidity including diabetes started at a high eGFR (8.7 ml/min/1.73 m2). Physician expe-
rience played a role in dialysis prescription. Non-specialists were more likely to prescribe
dialysis for life-threatening conditions, while older and more experienced physicians were
more likely to start dialysis for clinical reasons, and at a lower eGFR. Female doctors started
dialysis at a higher eGFR than males (8.0 vs. 7.1 ml/min/1.73 m2).
Conclusions
DI was prescribed mainly based on clinical reasons in accordance with current recommen-
dations while low renal function accounted for only 19% of primary reasons for DI. There are
considerable differences in physicians´ stated motivations for DI, related to their age, clinical
experience and interpretation of biochemical variables. These differences may be an inde-
pendent factor in the clinical treatment of patients, with consequences for the risk of
unplanned DI.
Introduction
In patients with chronic kidney disease (CKD), the mortality risk increases when glomerular
filtration rate (GFR) falls and becomes very high when GFR is below 15 ml/min/1.73m2. But, it
is not clear to what extent the high mortality risk in CKD stage 5 (CKD5) can be reduced by
earlier dialysis initiation (DI), and the precise cause(s) which in clinical practice motivates
chronic DI in patients with CKD5 at a particular time are not well studied. Thus, the optimal
timing and motivation of DI remains controversial. In the late 1990s, in the hope of preventing
malnutrition and avoiding increased mortality and complications linked to too late start of
dialysis therapy, estimated GFR (eGFR) at DI increased markedly [1–3]. According to the
United States Renal Data System (USRDS), the proportion of patients with eGFR>10 ml/min
at DI increased from 20% in 1996 to 52% in 2008. However, the benefits of “early dialysis
start” was challenged as the results of several large observational studies comparing outcomes
in patients starting dialysis at various levels of eGFR showed that starting dialysis at lower lev-
els of eGFR (= “late start”) associated with lower mortality. In 2010, the IDEAL study [4]
showed that in 828 patients randomized to early (eGFR 10–14 ml/min) or late (eGFR 5–7 ml/
min) dialysis start, there was no difference in survival or complications between the two
groups. On the other hand, 76% of the patients allotted to late dialysis had to start dialysis
before the target of<7 ml/min due to uremic symptoms. This led to recommendations that
dialysis primarily be initiated when patients become symptomatic [5], or if the patient has
severe renal insufficiency, <5 ml/min (reference 5) or<6 ml/min [6]. Thus, the concept of ter-
minal uremia, defined as advanced renal failure requiring permanent active treatment in order
to prevent death, disease or invalidity, is now limited to the continued presence of uremic
symptoms, life-threatening uncontrollable electrolyte disturbances, and/or severe renal failure.
These recommendations have stopped the accelerating trend towards earlier and earlier initia-
tion of dialysis based on eGFR.
A further problem with the IDEAL study is that patients were referred early to specialist
nephrological care, were closely monitored, and, as participants in a randomized controlled
trial, may have been atypical of the general terminal uraemia population. Probably as a result
of these factors, the incidence of urgent DI, defined as need for a temporary dialysis catheter
placement, was very low (3.7% for the early start and 8.3% for the late start group respectively)
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compared with the incidence of about 40% in most other clinical studies [7]. Urgent/
unplanned DI is undesirable since it is associated with a substantially increased risk of septice-
mia [8,9] and mortality [10,11]. While one cause for urgent/unplanned DI is delayed referral
of patients with CKD stage 4–5 to specialist nephrological care [12,13], the physicians´ motiva-
tion for starting dialysis has received little scientific attention. An international questionnaire
survey in 2000 [14], showed that 60% of physicians believed that clinical problems were the
most important factors for starting dialysis (nutritional status 14%, overhydration 8%, uremic
symptoms 38%), while 32% believed residual renal function (RRF) to be most important. Only
4% did not believe that early start had any clinical benefit. These figures would be expected to
be radically different in the post-IDEAL era. However, an international questionnaire study in
2012 [15] showed that a third of nephrologists considered RRF to be most important, rising to
54% for uncomplicated patients. The median eGFR requiring dialysis for uncomplicated
patients was 10 ml/min, varying between 5–20 ml/min, suggesting that many physicians
remain unconvinced of the implications of the IDEAL study. While the European Renal Best
Practice (ERBP) guidelines recommend the mean of urea and creatinine clearance as the opti-
mum method of evaluating RRF [5], most physicians—likely for practical reasons—continue
to prefer eGFR, albeit often in combination with another method. There is a continuing uncer-
tainty about the optimum timing of DI, the role of GFR and on what other grounds physicians
(should) initiate dialysis.
The Peridialysis project is an ongoing, multi-center, multinational prospective epidemio-
logical study investigating clinical practices up to DI and their immediate consequences (the
“peridialysis” period). In the present study, which is the first report from the project, we report
data concerning specific causes and timing of DI, focusing on physicians´ stated motivations
for prescribing dialysis, and correlations of causes and timing of DI with physician details. We
hypothesized that physician motivation for DI is a psychological/sociological phenomenon,
independent of other clinical and biochemical variables that may influence DI practices. In
particular, we hypothesized that some physicians will prescribe dialysis on mainly clinical
grounds, while others will prescribe on mainly biochemical grounds. This is an important dif-
ference, since it is possible that differences in physician motivation will affect the patient’s
prognosis and choice of dialysis modality.
Materials and methods
Eleven nephrology departments took part in this observational prospective questionnaire
study of causes and timing of DI. All delivered both peritoneal dialysis and hemodialysis. All
centers were publicly financed, with no dialysis costs to the patient, but with varying financial
support for medicine costs. The commonest method of assessing RRF and guiding clinical
treatment was eGFR as measured by the CKD-EPI formula.
Patients
All consecutive patients starting chronic dialysis therapy for ESRD between 1.1.2015 and
1.1.2016 at the participating centers were included in the current study. Some centers provided
additional data up to 1.7.2016. The patient was considered as having end-stage renal disease
(ESRD) at first dialysis if
1. The treating physician “believed” that the patient had ESRD at first dialysis
2. The patient received >90 days dialysis treatment
3. If the doctor was in doubt whether the patient had acute or chronic renal failure, the patient
was included retrospectively as soon as there was no doubt that the patient had ESRD
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The current study comprises 446 patients (median age of 67 years; 38% females) with
CKD5 who were investigated in conjunction with DI. Patient data are shown in Table 1. The
underlying renal diagnoses were: glomerulonephritis 19.3%, chronic interstitial nephropathy/
obstructive 9.4%, polycystic disease 7.4%, type 1 diabetes mellitus (DM) 6.3%, type 2 DM
17.3%, hypertensive nephropathy 17.9%, other 10.8% and unknown 11.7%.
Table 1. Clinical and laboratory characteristics at the time of dialysis initiation in 446 patients with
CKD5.
Mean ±SD Median (IQ range)
Age (years) 64.2 ±14,7 67.0 (55–75)
Females (n; %) 170; 38.0
Height (cm) 172 ±10 172 (165–179)
Body weight (kg) 79.4 ±21.7 75 (65–90)
Body weight non-diabetics 76.7 ±18.6 74 (64–87)
Body weight diabetics 88.6 ±28.2 83.5 (70–101)
Body mass index (kg/m2) 26.5 ±6.1 25.0 (22.5–29.3)
BMI non-diabetics 26.0 ±5.6 24.7 (22.3–28.4)
BMI diabetics 28.3 ±7.1 27.5 (23.2–30.9)
Number of comorbidities 1.39 ±1.4 1 (0–2)
Biochemical measurements
Creatinine (μM) 689 ±303 631 (508–797)
Hemoglobin (mM) 6.3 ±1.1 6.2 (5.6–6.9)
Potassium (mM) 4.5 ±0.8 4.4 (3.9–4.9)
Urea (mM) 33.7 ±11.9 31.8 (25.6–39.7)
Bicarbonate (mM) 20.9 ±5.2 21.0 (17.6–24.8)
Albumin (mM) 33.8 ±6.7 34 (29–39)
C-reactive protein (mg/l) 38 ±59 10 (3–49)
Ionized calcium (mM) 1.14 ±0.12 1.14 (1.07–1.21)
Phosphate (mM) 1.99 ±0.56 1.95 (1.60–2.31)
eGFR (ml/min/1.73 m2) 7.2 ±3.4 6.7 (5.0–8.7)
eGFR 3 months previously 14.0 ±13.6 10.1 (8.5–13.5)
Change in eGFR (ml/min/1.73 m2/yr) * 10.3 (3.7–21.6)
Comorbidities
Percent
Myocardial infarction 11.2
Cardiac failure 16.1
Cardiac disease 23.8
Cerebrovascular disease 12.6
Peripheral vascular disease 13.0
Diabetes 25.6
Cancer 13.7
Pulmonary disease 11.2
Hepatic disease 4.3
Psychiatric disease 4.7
Previous transplant 2.9
No comorbidity 19.7
*Not stated; a minority of patients had extreme values.
https://doi.org/10.1371/journal.pone.0188309.t001
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The study protocol was approved by the ethical review boards in centers located in coun-
tries where according to the country´s regulations such perusal was required. The study was
approved by the Swedish Ethical Committee (Ref 2017/7). However, in Denmark, due to the
observational non-interventional design of the study using anonymized patient data, the study
protocol was not considered to be eligible for ethical review. Informed consent—either written
or verbal depending on the regulations in the different countries—was obtained from partici-
pants in all centers including those in Denmark The study is registered with Clinical Trials.
gov, identifier NCT02488200
The datafile for this project is available on Open Science Framework, identifiers: DOI 10.
17605/OSF.IO/Z63JP, ARK c7605/osf.io/z63jp
Methods
Patient clinical data. The following patient data at DI were registered: age, sex, height,
weight, body mass index (BMI) and renal diagnosis. The presence of the following comorbidi-
ties was registered: previous myocardial infarction, heart failure, cardiac atherosclerosis, cere-
brovascular disease, diabetes, peripheral atherosclerosis, previous cancer (except basocellular),
chronic pulmonary disease, chronic liver disease, psychiatric disease, previous renal transplan-
tation, and other specified chronic conditions.
Patient biochemical data. The following biochemical data prior to or in conjunction with
first dialysis were registered: blood hemoglobin, plasma values of urea, creatinine, potassium,
hydrogen carbonate (bicarbonate), albumin, C-reactive protein (CRP), total or ionized cal-
cium, and phosphate. Most centers measured ionized calcium, for other centers, ionized cal-
cium was assumed to be 50% of total calcium.
Physician motivation questionnaire. Physicians gave details of their reasons for pre-
scribing chronic dialysis in an English language questionnaire (S1 Table). They could
choose between clinical and/or biochemical reasons. Since the terms used in the question-
naire were deemed to be clearly defined, no questionnaire validation for local translations
were performed.
Clinical reasons: pulmonary stasis, dyspnea, hypertension, pericarditis, oedema, cardiac
symptoms, fatigue, anorexia, nausea/vomiting, cachexia/weight loss, itching, insomnia,
depression, diarrhea, taste disturbances, social problems, practical problems, and other speci-
fied reasons.
Biochemical reasons (based on plasma values): high creatinine, high urea, low GFR, high
potassium, acidosis, low calcium, high calcium, high phosphate, falling GFR.
A primary reason for DI had to be specified, and a secondary was voluntary. In addition,
other reasons for DI could be stated by the physician who also was encouraged to register the
presence of uremic symptoms at dialysis prescription.
Physician data. Data on participating physicians (n = 84) were requested and for those
who agreed to have their data registered (n = 52, contributing to 74% of DIs)) data were anon-
ymized. They were asked to provide the following personal data: age, sex, specialist qualifica-
tion, duration of physician experience, and duration of specialist nephrology experience.
Statistics
Data are presented as mean ± standard deviation (SD) or median (interquartile, IQ, range) or
as numbers (percentage). Parametric variables were compared using the Students t-test and
MANOVA, and non-parametric using the Chi square and Kruskal-Wallis tests. A probability
level of<0.05 was considered significant. Significance values were expressed as p<0.05,
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p<0.01, p<0.001. For comparisons, variables were divided according to median value or as
tertiles.
Results
Dialysis initiation (DI) in 446 patients was prescribed by 84 doctors at 11 hospitals. Patient
data are shown in Table 1. The reasons (19 clinical and 11 biochemical) for prescribing dialysis
are shown in Table 2 and Fig 1 and clinical symptoms in Fig 2. The primary reason for DI was
clinical in 62.7% of cases, 16.4% had no biochemical indication, and 16.9% no clinical indica-
tion. 48.0% had 1–2 symptoms, 21.5% 3–4 and 13.6% >4 symptoms. Life threating conditions
(pulmonary stasis, dyspnea, pericarditis, cardiac symptoms, tetanus, hyperkalemia and
Table 2. Primary, secondary and additional other reasons, clinical and biochemical, for prescribing chronic dialysis initiation in 446 patients.
Primary Secondary Other Total
No. Percent No. Percent No. Percent No. Percent
Clinical
Pulmonary edema 46 10.3 2 0.2 2 0.4 50 11.2
Dyspnea 16 3.6 4 0.9 24 5.4 44 9.9
Hypertension 4 0.9 5 1.1 27 6.1 36 8.1
Pericarditis 2 0.4 1 0.2 4 0.9 7 1.6
Edema 37 8.3 16 3.6 40 9.0 92 21.1
Cardiac symptoms 4 0.9 8 1.8 13 2.9 25 5.6
Fatigue 97 21,7 43 9.6 80 17.9 220 49.3
Anorexia 9 2.0 25 5.6 62 13.9 96 21.5
Nausea 41 9.2 23 5.2 41 9.2 105 23.5
Cachexia/weight loss 9 1.8 10 2.2 36 8.1 55 12.3
Pruritis 9 2.0 13 2.9 52 11.7 74 16.6
Insomnia 0 0 3 0.7 22 4.9 25 5.6
Depression 0 0 2 0.4 17 3.8 19 4.3
Diarrhea 0 0 0 0 5 1.1 5 1.1
Taste disturbances 1 0.2 0 0 10 2.2 11 2.5
Cerebral symptoms 1 0.2 0 0 4 0.9 5 1.1
Social 0 0 0 0 5 1.1 5 1.1
Practical 3 0.7 1 0.2 1 0.2 5 1.1
Other 1 0.2 0 0 9 2.0 10 2.2
Any clinical 280 62.7 156 35.0 234 52.5 373 83.6
Life-threatening 102 22.9 178 40.0
Biochemical
High creatinine 30 6.7 26 5.8 101 22.6 157 35.2
Low eGFR 55 12.3 32 7.2 99 22.2 186 41.7
High creatinine or low eGFR 85 19.1 265 69.4
Falling eGFR 17 3.8 34 7.6 62 13.9 113 25.3
High urea 30 6.7 37 8.3 73 16.4 140 31.4
High potassium 23 5.2 13 2.9 25 5.6 60 13.5
Acidosis 10 2.2 17 3.8 47 10.5 74 16.6
Low calcium 0 0 2 0.4 13 2.9 15 3.4
High calcium 0 0 0 0 2 0.4 2 0.4
High phosphate 1 0.2 0 0 49 11.0 50 11.2
Any biochemical 166 37.2 161 36.1 228 51.1 371 83.1
https://doi.org/10.1371/journal.pone.0188309.t002
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acidosis) were the primary reason in 102 (22.9%) of cases. All 19 pre-stated clinical symptoms
that a priori were assumed to be main causes for DI were present in one or more of patients
and “other” clinical causes including ascites, freezing symptoms, muscle cramps, tetanus and
vertigo were also noted in some of the patients. Low renal function (high creatinine or low
eGFR) was the primary cause in 19.1% but low RRF was noted as a factor prompting DI
Fig 1. Primary reasons for chronic dialysis initiation (DI) in 446 patients with CKD5. Clinical reasons
accounted for 63% and biochemical reasons for 37% of all DI. The 12 most common motivations accounted
for 91% of all DI prescriptions, “fatigue” being most common (22%) among clinical motivations, and “low GFR”
(13%) most common among DI based on biochemical grounds.
https://doi.org/10.1371/journal.pone.0188309.g001
Fig 2. Uremic symptoms at dialysis initiation (DI) in 446 patients with CKD5 in percent. Symptoms were
present in 83% of patients, the most common being fatigue (44%), nausea (24%) and anorexia (22%). Black
bars: primary symptoms; hatched bars: secondary or other symptoms.
https://doi.org/10.1371/journal.pone.0188309.g002
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prescription in altogether 69.4% of the cases. Only 14 patients (3.1%) had an eGFR >15 ml/
min at DI.
Among the 84 prescribing physicians, 52 physicians, responsible for 332 (74.4%) of pre-
scriptions, supplied their personal details. Their age was 49 ±10 years, median 49 (interquar-
tile, IQ, range 41–58) years; and 27 (54%) were female. They had been qualified physicians for
22 +/- 10 years, median 22 (13–45) years, and 41 (79%) were specialist nephrologists, and had
been so for on average 13 ±9 years, median 13 (6–19) years. Females physicians were generally
younger (45.8 ±9.1 vs. 52.0 ±9.8 years, p<0.05). Fewer females were specialists (67% vs. 89%),
and fewer had long specialist experience (>13 years, 21% vs. 54%) as compared to the males.
There were considerable differences in the behavior of physicians, as shown in Table 3.
Older physicians were more likely to prescribe dialysis on primarily clinical grounds, but were
also more likely to include biochemical reasons in their prescription. Females were more likely
to initiate dialysis for primarily life-threatening reasons. Non-specialists were more likely to
include clinical grounds in their reasoning, and to start dialysis for life-threatening reasons.
Physicians with more specialist experience were more likely to give clinical reasons, and less
likely to give life-threatening reasons. There were no significant differences between the pre-
scribers in eGFR at first dialysis, though there was an insignificant trend for more experienced
doctors to start at a lower renal function, and total physician experience showed a similar pat-
tern to specialist experience.
When excluding patients with primary life-threatening reasons to take into account the
possibility that less experienced doctors were more likely to meet acutely ill patients, the results
were generally unchanged. However, female physicians started dialysis at a higher eGFR than
male doctors (8.0 ±3.6 ml/min vs. 7.2 ±3.5, p<0.05).
Table 3. The stated primary reason for dialysis initiation in 446 patients and characteristics of prescribing physicians (n = 52) who agreed to pro-
vide their details. Number and percent (in brackets).
eGFR Primary reason Clinical reasons Biochemical reasons 1˚ Life-threatening
reason
ml/min/1.73 m2 Clinical Biochemical None Some None Some Yes No
Age (yrs)
<50 7.8 ±.9 71 (51.4)*** 67 30 (21.7)** 108 13 (8.8)*** 125 38 (27.5)* 100
>49 7.3 ±3.3 139 (71.6) 55 21 (10.8) 173 47 (24.2) 147 35 (18.4) 154
Sex
Male 7.2 ±3.5 134 (62.6) 80 32 (14.9) 182 43 (20.1) 171 35 (16.4)*** 179
Female 8.0 ±3.6 76 (64.4) 42 19 (16.1) 99 17 (14.4) 101 38 (32.2) 80
Medical experience
<23 yrs 7.9 ±3.9 71 (51.8)*** 66 30 (21.9)** 107 13 (9.5)*** 124 38 (27.7)* 99
>22 yrs 7.2 ±3.3 139 (71.3) 56 21 (10.7) 174 47 (24.1) 148 35 (18.0) 160
Specialist experience
Nonea 8.0 ±4.8 31 (66.0) 16 2 (4.2)* 45 6 (12.7) 41 18 (38.3)** 29
<14 yrsb 7.6 ±3.5 64 (51.2)*** 61 34 (27.2)*** 91 16 (12.8)* 109 32 (25.6)* 93
>13 yrs 7.3 ±3.1 115 (71.8) 45 15 (9.3) 145 38 (23.8) 122 23 (14.4) 137
*:p<0.05;
**:p<0.01;
***:p<0.001;
a: significance values compared to specialists;
b:compared to specialists with more experience
https://doi.org/10.1371/journal.pone.0188309.t003
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The biochemical relationship to the biochemical reasons given for starting dialysis are
shown in Table 4. There was general agreement on the interpretation of the terms, with a con-
siderable overlap. Patients with a “high creatinine” had a slightly higher creatinine than those
without, but there was no significant difference in the corresponding eGFR. Similarly, patients
with a “low GFR”, had a significantly lower eGFR, but no difference in creatinine. The choice
of the terms “high creatinine” or “low eGFR” as primary reason did not relate to physician
details. There was no agreement on the meaning of the term eGFR.
We hypothesized that the following variables would correlate to clinical uraemia: eGFR,
BMI, albumin, bicarbonate, and CRP. The data are shown in Table 5. There were considerable
differences in the eGFR for the various primary problems. Patients with cachexia, anorexia
and pulmonary stasis had an eGFR of 8.2–9.8 ml/min, while patients with acidosis and edema
were characterized by a low eGFR (4.6–6.1 ml/min). BMI was broadly similar, but cachectic
patients had as expected a lower level, on average 21.3 kg/m2. Conditions characterized by
hypoalbuminemia (33 g/l) included pulmonary stasis, hyperkalemia, dyspnea, edema and
acidosis. A low bicarbonate (20 mM) was seen in patients with hyperkalemia, and in those
with a rapidly falling eGFR, or cardiac symptoms. Pulmonary stasis, dyspnea, acidosis and
hyperkalemia were generally associated with inflammation (CRP>24 mg/l). Patients with pri-
marily clinical grounds for DI and/or no biochemical reasons had a significantly higher eGFR.
Patients with life-threatening conditions were generally biochemically abnormal, with hypoal-
buminemia, acidosis and a raised CRP.
Correlations to renal diagnosis, patient sex and age are shown in Table 6. eGFR was not
related to diagnosis, but in a post hoc analysis, eGFR was higher in patients with diabetic
nephropathy (p<0.05). Diabetics were more likely to start dialysis on clinical indications.
Patient sex was not related to eGFR or physician motivation. Younger patients (<60 years)
were more likely to start because of life-threatening conditions.
The presence of comorbidity had a major influence on biochemistry and DI (Table 7).
Patients with more than three comorbidities started dialysis at an eGFR that was 2.3 ml/min
higher than patients with none, 8.7 ±4.7 vs 6.4 ±2.6 ml/min. CRP rose continuously, and albu-
min fell with increasing comorbidity. A post hoc Spearman correlation analysis revealed albu-
min and CRP to be highly inversely correlated (R = -0.40, p<0.001). Patients with pulmonary
stasis had a significantly higher prevalence of heart failure (34% vs. 14%, p<0.001).
Table 4. Biochemical primary reasons for dialysis initiation in 446 patients as stated by prescribing physicians (n = 84) and how these reasons
relate to the corresponding measurements in presence or absence of stating these reasons as a cause to start dialysis.
Term Present Absent P
No. Mean ±SD Median (IQ range) No. Mean ±SD Median (IQ range)
High creatinine (μM) 30 781 ±333 707 (545–947) 282 675 ±343 635 (495–790) (0.06)
(corresponding eGFR (ml/min/1.73 m2)) 6.5 ±3.3 5.6 (4.3–8.4) 7.2 ±3.5 6.6 (5.0–8.7) NS
Low eGFR (ml/min/1.73 m2) 51 6.1 ±2.1 5.9 (4.8–7.4) 251 7.6 ±3,7 6.9 (5.1–9.4) <0.01
(corresponding creatinine (μM)) 719 ±258 669 (576–825) 678 ±317 627 (575–825) NS
Falling eGFR (ml/min/1.73 m2/yr 11 9.2 (2.4–47.6) 238 11.7 (4.3–22.5) NS
High urea (mM) 30 42.2 ±15.6 39.6 (33.0–49.2 298 32.0 ±11.2 29.5 (24.9–38.5) <0.001
High potassium (mM) 22 5.7 ±1.3 6.0 (4.5–6.5) 364 4.3 ±0.7 4.3 (3.9–4.8) <0.001
Acidosis (mM) 10 16.0 ±8.7 13.6 (10–19) 305 21.7 ±4.9 22 (18–25) <0.001
Low calcium* 15 0.96 ±0.11 0.96 (0.86–1.02) 402 1.14 ±0.12 1.15 (1.08–1.22) <0.001
High phosphate* 44 2.17 ±0.57 2.04 (1.83–2.33) 367 1.97 ±0.55 1.92 (1.56–2.30) <0.05
*primary, secondary and other reasons combined.
https://doi.org/10.1371/journal.pone.0188309.t004
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Discussion
There are few studies of clinicians’ motivation for prescribing dialysis, and this is the first com-
prehensive prospective study in the post-IDEAL era. There were 21 primary causes stated by
the 84 prescribing physicians as reason for starting dialysis among the 446 patients, illustrating
that terminal uraemia is a kaleidoscopic condition. While most patients (63%) started dialysis
on primarily clinical grounds, low renal function was the primary reason in only 19% of cases:
however, residual renal function was stated as playing a role in 69% of cases. The physicians
seem generally to be following the conclusions of the IDEAL study [4] and recommendations
from ERBP [5], the Canadian Society of Nephrology [16] and KDOQI [17] that the decision to
initiate maintenance dialysis should be based primarily on assessment of signs and/or symp-
toms of uraemia and related conditions such as fluid overload and secondly in the presence of
severe renal failure (GFR <5–6 ml/min). There has been some criticism of the conclusions of
the IDEAL study [18]. Clinical uremia was not clearly defined in the study. Fig 2 suggests that
Table 5. Biochemical correlates to primary reasons, ranked according to eGFR.
eGFR
(ml/min/1.73 m2)
BMI
(kg/m2)a
Albumin
(g/l)
Bicarbonate
(mM)
C-reactive protein
(mg/l)b
Cachexia 9.8 ±5.7 21,3 ±3.3 34,8 ±3.3 21,9 ±6.4 3 (1–3)
Pericarditis 8.9 ±3.8 28,1 ±1.8 31,0 ±5.7 24,0 ±8.5 158 (-)
Anorexia 8.4 ±1.8 27,7 ±6.2 36,8 ±7.1 22,2 ±3.3 7 (3–17)
Pulmonary stasis 8.2 ±4.8 27,6 ±7.6 32,0 ±6.5 20,5 ±5.7 38 (9–91)
Falling eGFR 8.1 ±3.5 23,2 ±3.7 34,8 ±7.1 19,4 ±3.4 22 (4–72)
Itching 7.9 ±3.4 24,8 ±4.5 34,1 ±9.8 21,6 ±2.6 24 (5–37)
Fatigue 7.9 ±3.5 26,8 ±5.7 35,0 ±6.2 21,6 ±4.9 5 (3–25)
Cardiac symptoms 7.5 ±4.8 25,4 ±4.4 35,7 ±4.9 19,0 ±2.6 20 (1–139)
High potassium 7.3 ±3.3 24,9 ±7.9 32,4 ±7.5 18,6 ±4.9 25 (4–75)
High urea 7.2 ±3.5 24,6 ±4.0 33,5 ±5.4 20,8 ±5.7 14 (3–60)
Nausea 7.0 ±3.3 24,2 ±5.0 32,9 ±8.0 20,8 ±4.6 3 (3–33)
High creatinine 6.5 ±3.3 25,0 ±4.4 35,1 ±6.4 20,3 ±5.8 12 (10–146)
Dyspnea 6.3 ±2.3 29,0 ±6.7 31,2 ±7.1 19,9 ±6.6 65 (10–146)
Hypertension 6.3 ±2.6 31,0 ±9.4 36,3 ±1.5 19,0 ±2.0 9 (2–24)
Edema 6.1 ±2.0 25,9 ±5.2 30,1 ±6.1 20,3 ±5.5 19 (3–86)
Low eGFR 6.1 ±2.1 25,8 ±4.7 36,5 ±6.2 22,4 ±4.1 5 (3–20)
Acidosis 4.6 ±2.3 27,6 ±6.1 31,1 ±7.9 16,0 ±8.7 29 (3–69)
Motivational groups
Primary Clinical 7.5 ±3.6** 26.3 ±5.9 33.4 ±6.7 21.1 ±5.1 10 (3–54)
Primary Biochemical 6.6 ±3.0 25.2 ±5.1 34.7 ±6.6 20.6 ±5.4 11 (3–44)
Life-threatening 7.3 ±4.0 26.2 ±5.9 31.9 ±6.8*** 19.5 ±6.1*** 37 (5–91)***
Not life-threatening 7.4 ±3.3 25.7 ±5.4 35.1 ±6.6 22.0 ±4.7 6 (3–30)
No clinical 7.1 ±3.1 26.0 ±5.7 34.9 ±7.2 20.6 ±5.4 9 (3–53)
Some clinical 7.2 ±3.5 25.8 ±5.7 33.6 ±6.6 21.0 ±5.1 11 (3–49)
No biochemical 8.2 ±3.6** 25.0 ±5.6 34.2 ±6.7 20.5 ±5.2 12 (3–86)
Some biochemical 7.0 ±3.3 26.0 ±5.7 33.7 ±6.7 21.0 ±5.2 9 (3–45)
All 7.2 ±3.4 25.8 ±5.7 33.8 ±6.7 20.9 ±5.2 10 (3–49)
aexcluding patients with type 2 DM;
b: Median (IQ range);
**:p<0.01;
***:p<0.001
https://doi.org/10.1371/journal.pone.0188309.t005
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the primary uremic symptom is fatigue, and this symptom may not necessarily be alleviated by
dialysis [19], particularly if symptoms are caused by comorbid disease or hemodialysis side
effects. If the cause of dialysis initiation is non-life-threatening uremic symptoms, the final
decision should whenever possible be made by the patient, who must balance symptomatology
against the inconvenience of dialysis. There are no financial incentives for early or late start of
dialysis in the countries involved in this study; it is possible that the presence of such incentives
could lead to suboptimal patient treatment [18].
Previous studies have reported uremic symptoms at DI.[20–23] The methodology of these
differed from the present study in a number of ways: two were based upon patient notes,
[21,23] one on objective assessment rather than symptoms [20]. In one study patients with
Table 6. Correlations to renal diagnosis, patient sex and patient age. No. patients (%).
eGFR Primary reason Clinical reasons Biochemical reasons 1˚ Life-threatening
reason
ml/min/1.73 m2 Clinical Biochemical None Some None Some Yes No
Diagnosis
Diabetic 7.8 ±3.2*a 81(77.1)***b 24 11 (10.5 94 19 (18.1) 86 27 (25.7) 78
Polycystic 7.6 ±2.5 17 (51.5) 16 4 (12.1) 29 7 (21.2) 26 8 (24.2) 25
Unknown 7.1 ±2.7 31 (59.6) 21 9 (17.3) 43 9 (17.3) 43 12 (23.1) 40
Chronic interstitial 7.1 ±3.5 26 (61.9) 16 9 (21.3) 33 7 (16.7) 35 10 (23.8) 32
Other 7.1 ±5.7 27 (56.3) 21 9 (18.8) 39 5 (10.4) 43 15 (31.2) 33
Hypertesnive 7.0 ±2.8 48 (60.0) 32 16 (20.0) 64 15 (18.8) 65 15 (18.7) 65
Glomerulonephritis 6.7 ±3.2 50 (58.1) 36 14 (16.3) 72 13 (15.1) 73 15 (17.4) 71
Sex
Male 7.4 ±3.5 171 (62.0) 105 42 (15.2) 234 49 (17.8) 227 70 (25.3) 206
Female 7.0 ±3.2 109 (64.5) 60 30 (17.8) 139 26 (15,4) 143 32 (18.9) 137
Age (years)
<60 7.1 ±3.8 94 (63.1) 55 21 (14.1) 128 17 (11.4) 132 26 (17.5)*c 123
60–71 7.4 ±3.3 91 (64.5) 50 23 (16.3) 118 31 (22.0) 110 34 (24.1) 107
>71 7.1 ±3.2 91 (61.1) 58 26 (17.5) 123 27 (18.1) 122 42 (28.1) 107
*:p<0.05;
***:p<0.001;
a: see text;
b: versus other diagnoses;
c: versus other age groups.
https://doi.org/10.1371/journal.pone.0188309.t006
Table 7. Proportion of clinical causes as reason for dialysis initiation and selected measurements in relation to number of comorbidities.
No. comorbidities No. Primary clinical cause
(%)**
eGFR
(ml/min/1.73 m2)***
BMI
(kg/m2)a
Albumin
(g/l)**
Bicarbonate
(mM)
C-reactive protein
(mg/l)***
0 137 58 6,4 ±2.6 26,0 ±5.5 35,6 ±6.8 20,5 ±5.0 4 (3–26)
1 148 59 7,2 ±3.7 25,6 ±5.8 33,6 ±6.6 21,3 ±5.3 8 (3–35)
2 71 65 7,0 ±2.4 26,6 ±6.2 33,3 ±7.0 21,2 ±5.2 20 (3–71)
3 47 72 8,1 ±3.8 25,3 ±5.8 33,2 ±5.7 19,5 ±5.3 18 (9–76)
>3 43 79 8,7 ±4.7 25,3 ±4.3 31,0 ±6.2 21,4 ±5.0 37 (9–73)
aexcluding patients with type 2 DM;
**:p<0.01;
***:p<0.001
https://doi.org/10.1371/journal.pone.0188309.t007
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acute uremia were excluded [22] and another was limited to nursing home patients[20]. DI in
these studies occurred at a higher eGFR, varying from 8.9 ml/min [21] to 11.0 ml/min [23].
O’Hare [23] found a DI eGFR>15 ml/min in 16% of patients, and Kurella 18% [20]. Signifi-
cant causes of early DI were edema and dyspnea. Since only 3% of our patients started DI at an
eGFR>15 ml/min, this suggests that these symptoms can usually be controlled by conserva-
tive measures, e.g. diuretics, fluid restriction and sodium bicarbonate supplements.
Seventeen percent of our patients had no uremic symptoms at DI, generally in accordance
with other studies: 12% [22] and 18% [20]. However, there is some disagreement concerning
the number of symptoms. 22% of our patients had >2 symptoms, compared to 20% in the
Kurella study [20] and 61% in the Curtis study [22]. There is general agreement that fatigue,
nausea, anorexia, volume overload and itching are the commonest uremic symptoms.
The symptoms of uraemia are often non-specific, and many patients probably started dialy-
sis for reasons other than uraemia, in that patients with multiple comorbidity, including diabe-
tes and with probable symptoms related to these, started dialysis earlier than non-comorbid
patients. Similarly, patients with pulmonary stasis started dialysis early. This may have been
due to unrelated cardiac failure (in 34% of the cases), but suggests that increased attention to
volume control in these patients could have postponed dialysis requirement. Patients starting
due to pulmonary stasis and dyspnea had very high values of CRP, suggesting that complicat-
ing pneumonia may have been a partial cause of their distress.
One surprising fact is that cachexia and/or weight loss was the primary indication in only
2% of patients. A previous survey [14] showed that nutritional problems were considered to be
an important reason for starting dialysis. Plasma albumin has often been used as a marker of
malnutrition. This is probably erroneous: in this study, albumin was a marker of increasing
morbidity and inflammation as measured by CRP. The interplay between protein malnutrition
and inflammation is a complex issue, since albumin is both a marker of nutrition and of
inflammation. Patients who are sarcopenic often have increased inflammation (the “malnutri-
tion-inflammation-atherosclerosis syndrome”). This will further have complicated the deci-
sion algorithm for physicians prescribing dialysis on mainly biochemical grounds.
Furthermore, patients suffering from pulmonary stasis, dyspnea, or edema were character-
ized by hypoalbuminemia, suggesting a dilutional effect. Patients who started dialysis on life-
threating clinical grounds generally had a lower p-albumin and higher C-reactive protein.
There were considerable differences between doctors according to clinical experience. The
higher proportion of prescription of dialysis for life-threatening reasons among non-specialists
could be related to their probable closer contact with acutely ill patients. In contrast, older doc-
tors (>49 years) and specialists with >13 years of specialist experience were most likely to
state primarily clinical reasons for DI. It is possible that these physicians are those most likely
to accept the implications of the IDEAL study. Correspondingly, more experienced physicians
tended to start dialysis at a lower eGFR. Differences between male and female doctors were rel-
atively minor, but females started dialysis at a higher eGFR than males, probably due to their
higher contact with acutely ill patients.
There appeared to be general agreement on the meaning of the biochemical indications for
dialysis, but with considerable overlap. This overlap could either be due to real disagreement
about the meaning of the terms, or disagreement about what level indicates DI, but implies
that there is a considerable variation among doctors as to the optimal timing of DI. In general,
doctors started dialysis purely on the basis of renal function only if the eGFR was about 6 ml/
min. All in all, this paper demonstrates considerable confusion among physicians concerning
definitions and their reasons to start dialysis.
A priori, one would expect the terms “high creatinine” and “low eGFR” to be equivalent;
this was however not the case, in that patients with “high creatinine” at DI had similar eGFR as
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other patients, and vice versa. The choice of terms was not related to physician experience.
They thus seem to be perceived as slightly different concepts, the clinical meaning of this dif-
ference being unclear. It may be that “high creatinine” is used by physicians who are skeptical
about the meaning of eGFR (vide infra). There was no agreement as to what constituted a rate
of loss of eGFR that indicated dialysis start. However, rate of loss of eGFR during the last 1–2
months before dialysis was not registered, and might have revealed significant differences.
There is substantial evidence that eGFR is not a reliable measure of renal function in
patients with CKD5. Paradoxically, a high eGFR at DI was reported to associate with increased
mortality [1,24–26]. This may be due to the fact that many of these patients are malnourished,
with reduced muscle mass and low creatinine production, and as a consequence a “falsely”
raised eGFR [24,27,28]. Our results support this hypothesis in that patients with cachexia and
anorexia had the highest values of GFR, and support the current recommendations of the
ERBP guidelines that the average of creatinine and urea clearances, measured from a 24-hour
urine collection, should be the preferred method of assessing renal function in CKD5 [5].
However, in the present study, there was no relationship between eGFR and patient age sug-
gesting that age related alterations in body composition such as sarcopenia did not play a role
as modifier of eGFR. Another possible explanation for the paradoxical relationship of higher
eGFR with increased mortality is that patients with a high eGFR may have more comorbidity,
and therefore start dialysis earlier, as previously described [29]. It is possible that dialysis may
not be strictly necessary for these patients, but it is in practice often impossible for the physi-
cian to distinguish symptoms of uraemia from other diseases, and, in addition, as mentioned
above, comorbid patients are usually malnourished and may have a “falsely” raised eGFR.
There are several limitations, which should be taken into account when interpreting the
results of the present study. One important problem that is not addressed by the study is the
converse question “Why do physicians not prescribe dialysis?” This question does not involve
the question as to whether to withhold active treatment either due to severe comorbidity or
due to patient choice, but the fact that all contacts to patients with CKD stage 5 must address
this question. The answer might be somewhat different from just the absence of reasons for
starting dialysis. The study does not reliably supply insights into the true "why" of the psychol-
ogy of dialysis start today and not tomorrow. For that aim, qualitative research, or vignette
studies, should be better suited. In the current setting, respondents can only provide answers
already selected for them. The study was limited to the “peridialysis” period and did not
include analysis of patient referral to nephrology care, or GFR trajectories and appearance of
symptoms and signs and how they were treated during the months or years preceding DI;
such information was most likely considered and should have influenced the decisions by the
prescribing physicians. So far, the prospective data on the consequences of timing and motiva-
tion of DI are not yet available, and therefore no conclusions can be made as regards the impli-
cations of the observed findings. The relatively low number of patients, and the low number of
prescribing physicians, reduces the statistical power while the generalizability of the study is
confined mainly to the Nordic area where the study was performed. On the other hand, a
major strength of the study is that it used a more detailed questionnaire about the causes for
DI and that it collected information about the prescribing physicians. Furthermore, the study
addresses an area where few recent studies have been conducted.
Conclusions
In conclusion, this first report from the prospective questionnaire Peridialysis study on timing
and causes prompting physicians to prescribe maintenance dialysis shows that dialysis initia-
tion was mainly motivated on clinical grounds whereas eGFR and other indices of renal
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function loss appear to have had more of a supportive role for their decisions. There were con-
siderable differences in motivations stated by physicians for prescribing dialysis, which are
related to their age and clinical experience. These differences may be an independent factor
in the clinical treatment of patients with consequences for the risk of unplanned dialysis
initiation.
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